Home
Our services
About us
LDO services
Our clients
Member area
Conferences
Upcoming events
18th EFMC Short Course on Medicinal Chemistry
4th Edelris Symposium
3rd EFMC Tandem Talks
PREP 2024
BPG 2024
10th NovAliX Conference
NMCS Seattle
BOSS XVIII
RICT 2024
EFMC-ISMC 2024
EFMC-YMCS 2024
IP24
24th EuroQSAR
SPICA 2024
Future events
Archives
Contacts us
Contact us
Sign up to our emails
Home
Our services
About us
LDO services
Our clients
Member area
Conferences
Upcoming events
Future events
Archives
Contacts us
Contact us
Sign up to our emails
Menu
LD Organisation
Scientific Conference Producers
Confirmed Plenary lectures
Translocator Protein as a Promising Target for Novel Anxiolytics
Prof. Federico DA SETTIMO
UNIVERSITÀ DI PISA, Pisa, Italy
Drug-to-Genome-to-Drug: Discovery and Optimisation of an Antimalarial Compound
Prof. Benoit DEPREZ
INSTITUT PASTEUR OF LILLE, Lille, France
New Selective Androgen Receptor Modulators (SARM) for the Treatment of Cachexia
Dr Pierre DEPREZ
GALAPAGOS, Romainville, France
Therapeutic Targeting of TLR Signalling
Dr Brian KEOGH
OPSONA THERAPEUTICS LTD, Dublin 8, Ireland
Targeting GSK-3 with ATP Non-Competitive Inhibitors: From the Bench to the Clinical Trials
Prof. Ana MARTINEZ
INSTITUTO DE QUIMICA MEDICA-CSIC, Madrid, Spain
New Targets for the Treatment of HIV
Dr David PRYDE
PFIZER GLOBAL R&D, Sandwich, United Kingdom
Confirmed Oral Communications
Can Medicinal Chemistry Solve Target Related Issues?
Dr Sandro BOLAND
AMAKEM NV, Diepenbeek, Belgium
Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Discovery of an Orally Active TDO Inhibitor
Prof. Raphaël FREDERICK
FUNDP, Brussels-Woluwe, Belgium
MASPIT, a Strategy for Small Molecule-Protein Interaction Mapping in Intact Human Cells
Dr Sam LIEVENS
UGENT/VIB, Gent, Belgium
Printer friendly version